You just read:

SAVSU Technologies Provides Performance Update on evo® Cold Chain 2.0™ System in ImmunoCellular Therapeutics Phase 3 Glioblastoma Cell Therapy Clinical Trial

News provided by

SAVSU Technologies

Feb 14, 2017, 05:00 ET